Cargando…

Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis

BACKGROUND: cMyc and p27 are key genes implicated in carcinogenesis. Whether polymorphisms in these genes affect breast cancer risk or prognosis is still unclear. In this study, we focus on a rare non-synonymous polymorphism in cMyc (N11S) and a common polymorphism in p27 (V109G) and determine their...

Descripción completa

Detalles Bibliográficos
Autores principales:	Figueiredo, Jane C, Knight, Julia A, Cho, Stewart, Savas, Sevtap, Onay, U Venus, Briollais, Laurent, Goodwin, Pamela J, McLaughlin, John R, Andrulis, Irene L, Ozcelik, Hilmi
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906827/ https://www.ncbi.nlm.nih.gov/pubmed/17567920 http://dx.doi.org/10.1186/1471-2407-7-99

Ejemplares similares

Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario
por: Briollais, Laurent, et al.
Publicado: (2007)

SNP-SNP interactions in breast cancer susceptibility
por: Onay, Venüs Ümmiye, et al.
Publicado: (2006)

Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk
por: Onay, Ummiye V, et al.
Publicado: (2008)

Phosphorylation states of cell cycle and DNA repair proteins can be altered by the nsSNPs
por: Savas, Sevtap, et al.
Publicado: (2005)

Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR)
por: Tram, Eric, et al.
Publicado: (2011)

A proteomic study of cMyc improvement of CHO culture
por: Kuystermans, Darrin, et al.
Publicado: (2010)

Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts
por: Heffernan, Corey, et al.
Publicado: (2012)

A Whole-Genome SNP Association Study of NCI60 Cell Line Panel Indicates a Role of Ca(2+) Signaling in Selenium Resistance
por: Savas, Sevtap, et al.
Publicado: (2010)

Missense Variants of Uncertain Significance (VUS) Altering the Phosphorylation Patterns of BRCA1 and BRCA2
por: Tram, Eric, et al.
Publicado: (2013)

Human SNPs resulting in premature stop codons and protein truncation
por: Savas, Sevtap, et al.
Publicado: (2006)

Transformation of normal cells by aberrant activation of YAP via cMyc with TEAD
por: Nishimoto, Masazumi, et al.
Publicado: (2019)

Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma
por: Lin, Yun Hsiao, et al.
Publicado: (2021)

Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: Potential breast cancer risk alleles and their distribution across human populations
por: Savas, Sevtap, et al.
Publicado: (2006)

Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8
por: Anderson, David A., et al.
Publicado: (2021)

Convergence of cMyc and β‐catenin on Tcf7l1 enables endoderm specification
por: Morrison, Gillian, et al.
Publicado: (2015)

SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of cMYC oncoprotein
por: Geng, Chuandong, et al.
Publicado: (2017)

cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis
por: Sakr, Hany I., et al.
Publicado: (2017)

Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer
por: Zhu, Hongwen, et al.
Publicado: (2023)

NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells
por: Savas, Sevtap, et al.
Publicado: (2011)

Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
por: Loftus, Róisín M., et al.
Publicado: (2018)

PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis
por: Qin, Yi, et al.
Publicado: (2019)

The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
por: Xu, Lei, et al.
Publicado: (2019)

Association of CMYC polymorphisms with hepatoblastoma risk
por: Yang, Tianyou, et al.
Publicado: (2020)

AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development
por: Takizawa, Makiko, et al.
Publicado: (2008)

cMyc increases cell number through uncoupling of cell division from cell size in CHO cells
por: Kuystermans, Darrin, et al.
Publicado: (2009)

The Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc()()
por: Prensner, John R., et al.
Publicado: (2014)

Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc
por: Luo, Haitao, et al.
Publicado: (2010)

MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN
por: Chen, Pan, et al.
Publicado: (2016)

TRIM66 Overexpression Promotes Glioma Progression and Regulates Glucose Uptake Through cMyc/GLUT3 Signaling
por: Song, Yuequn, et al.
Publicado: (2021)

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
por: Nyquist, Michael D., et al.
Publicado: (2023)

Sequence-to-expression approach to identify etiological non-coding DNA variations in P53 and cMYC-driven diseases
por: Kin, Katherine, et al.
Publicado: (2023)

Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming
por: Simula, Luca, et al.
Publicado: (2018)

cMyc/miR-125b-5p Signalling Determines Sensitivity to Bortezomib in Preclinical Model of Cutaneous T-Cell Lymphomas
por: Manfè, Valentina, et al.
Publicado: (2013)

RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
por: George, Jasmine, et al.
Publicado: (2021)

Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma
por: Jiang, Houxiang, et al.
Publicado: (2023)

Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines
por: Eng, Lawson, et al.
Publicado: (2011)

A novel rapid-onset high-penetrance plasmacytoma mouse model driven by deregulation of cMYC cooperating with KRAS12V in BALB/c mice
por: Hu, Y, et al.
Publicado: (2013)

microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer
por: Kim, Sinae, et al.
Publicado: (2018)

Human bone marrow-derived mesenchymal stem overexpressing microRNA-124-3p inhibit DLBCL progression by downregulating the NFATc1/cMYC pathway
por: Zhao, Xiaoxuan, et al.
Publicado: (2023)

Genome Wide Screening of CAG Trinucleotide Repeat Lengths in Breast Cancer
por: Jarjanazi, Hamdi, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_0baehb5njm6sork60a5sdkoh2t